QOL Medical, LLC

QOL Medical, LLC is a patient-centric company with a focus on the acquisition and commercialization of orphan therapies in underserved markets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of orphan diseases. QOL Medical currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection 5%.

Pharmaceuticals